Merck invests in radiopharmaceuticals startup’s $84M round


With new investment from Merck & Company Inc., a Boston-based radiopharmaceuticals startup now has the backing of three Big Pharma companies.

Previous Viewpoint: Pharmacy conference returns to Boston after 3 years of fighting pandemic
Next EXCLUSIVE: Pharma services firm opens new facility south of Boston